NYSE · Healthcare
STRYKER CORP (SYK)
As-reported financials and recent SEC filings for STRYKER CORP, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$25.12B
Net income
$3.25B
Net margin
12.9%
Diluted EPS
$8.40
ROE
14.5%
P/E (TTM)
36.1×
Market cap
$119.69B
Debt / equity
0.7×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $25.12B | $22.59B | $20.50B | $18.45B | $17.11B |
| Gross profit | $16.07B | $14.44B | $13.06B | $11.58B | $10.97B |
| Operating income | $4.89B | $3.69B | $3.89B | $2.84B | $2.58B |
| Net income | $3.25B | $2.99B | $3.17B | $2.36B | $1.99B |
| Diluted EPS | $8.40 | $7.76 | $8.25 | $6.17 | $5.21 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-02
View on EDGAR →42026-05-29
View on EDGAR →1442026-05-28
View on EDGAR →42026-05-28
View on EDGAR →1442026-05-27
View on EDGAR →SD2026-05-22
View on EDGAR →8-K2026-05-20
View on EDGAR →42026-05-12
View on EDGAR →Go deeper on SYK
Search STRYKER CORP’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.